Upload File

cber tissue safety team

Download CBER Tissue Safety Team

If you can't read please download the document

Post on 12-Feb-2016

47 views

Category:

Documents

0 download

Report

Embed Size (px)

DESCRIPTION

CBER Tissue Safety Team. Ruth Solomon, M.D. Director Division of Human Tissues OCTGT/CBER/FDA Blood Products Advisory Committee May 1, 2008. Outline. Background What are HCT/Ps? How are they regulated? What is an Adverse Reaction? Which Adverse Reactions must be reported? - PowerPoint PPT Presentation

Recommended

FDA Oversight of Cell Therapy Clinical Trials Celia Witten, Ph.D., M.D. Office Director, Office of Cellular, Tissue, and Gene Therapies CBER/FDA ISSCR/CIRM/ISCT
CBER Managed Review Process Sheryl A. Kochman Deputy Director, DBA, OBRR, CBER September 15, 2009
CBER Data Standards Management
Preparing an IND Application: CBER Breakout Session - 02... Preparing an IND Application: CBER Breakout
CBER-LIED Report on Housing Market Page 1 CBER and Lied Institute Report Volume CBER-LIED Report on
CBER Introduction to license application:
Standardization – CBER update
Importing and Exporting CBER-Regulated Products CBER-Regulated Products. Center for Biologics Evaluation and Research (CBER) Regulates biological and related products, including blood
pbis cber swis Donna Morelli and Cynthia Zingler
CBER CBER 510(k) Issues Sheryl A. Kochman, MT(ASCP) Chief, Devices Review Branch DBA/OBRR/CBER IVD Roundtable – OIVD Workshop April 23, 2003
CBER Biomechanics Research Symposium, 2007 2007 ... CBER Biomechanics Research Symposium, 2007 2 Time
Importing and Exporting CBER-Regulated Products of Case Management. ... Exporting CBER-Regulated Products. Center for Biologics Evaluation and ... – Import-for-Export (IFE)
Meeting the Challenges of Blood, Vaccine, and Tissue Safety Jesse L. Goodman, MD, MPH Director, Center for Biologics Evaluation and Research (CBER) Presentation
CBER September 15, 2009 License Supplements under 21 CFR 601.12 Hoi-may Wong, BS, MT(ASCP)SBB Consumer Safety Officer CBER, OBRR, DBA
CBER Whole Blood and Blood Component Labeling Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 16, 2009
CBER Perspective VRBPAC Meeting, November 16, 2010
Key Points - CBER Data 2016-03-01آ  Economic Outlook and the Ball State Business Roundtable. The CBER
ENSURE CMC SUCCESS AND EXPEDITE YOUR PRODUCT’S PATH Team Leader, Analytical Chemistry, FDA/CBER/OCBQ/DBSQC
Center for Biologics Evaluation and Research (CBER) Center for Biologics Evaluation and Research (CBER)
DEVELOPING SEND FOR CBER - Lex Jansen DEVELOPING SEND FOR CBER –COLLABORATIVE WORKSTREAM INITIATIVE
View more >